Latest 8-K filings

BCB Bancorp Inc. announced a second-quarter net loss of $14.8 million, a significant downturn from the previous quarter and year-ago period, while also proposing a move of its state of incorporation to Delaware.

Ocular Therapeutix announced a clear FDA-aligned path for its AXPAXLI NDA submission in Q4 2026, supported by positive Phase 3 data and a strong cash position extending into 2028.

SmartKem, Inc. announced a definitive agreement to combine with Ferrox Critical Minerals, Ltd. in an all-stock transaction valued at approximately $125 million, aiming for vertical integration.

TG Therapeutics reported robust second quarter 2026 results, driven by significant BRIUMVI revenue growth, leading to an upward revision of full-year financial targets.

Tonix Pharmaceuticals announced positive minutes from a Type C FDA meeting, confirming alignment on the design for a Phase 2 field study of its TNX-4800 to prevent Lyme disease.

Krystal Biotech announced robust second quarter 2026 financial and operating results, highlighted by significant global revenue growth for VYJUVEK and promising updates across its diverse clinical pipeline.

Seaport Therapeutics announced its second quarter 2026 financial results, detailing progress in its clinical trials for major depressive disorder and generalized anxiety disorder, alongside a robust cash position post-IPO.

Genprex, Inc. announces a collaboration with Roche Diagnostics to validate TROP2 and PTEN biomarkers for patient selection in non-small cell lung cancer clinical trials.

D-Wave Quantum Inc. and Nasdaq Verafin have announced a collaboration to explore the use of quantum computing for enhanced financial crime detection.

Two Harbors Investment Corp. announces progress on its merger with CrossCountry Intermediate Holdco, LLC, clarifying dividend details and anticipating closing upon final regulatory approval.

Autolus Therapeutics plc has entered into a $250 million senior secured notes facility with Perceptive Credit Holdings V, LP, alongside the issuance of warrants, to fund its operations and development.

BioXcel Therapeutics has entered into an Eleventh Amendment to its Credit Agreement, deferring a principal payment and reducing liquidity covenants.

Glaukos Corporation presented an investor presentation highlighting its innovative pipeline, strong financial health, and strategic focus on interventional glaucoma and keratoconus treatments.

Public Policy Holding Company, Inc. announces the acquisition of The Advocacy Partners, a Florida-based government relations firm, expected to be immediately earnings and margin accretive.

Marriott International announced robust second quarter 2026 financial results, driven by global RevPAR growth and a record development pipeline, leading to an upward revision of full-year RevPAR expectations.

Southern Company announced proposed offerings of $2.15 billion in convertible senior notes due 2027 and 2029 to fund debt repayment and general corporate purposes.

Indivior Pharmaceuticals announced robust second-quarter 2026 financial results, exceeding expectations with significant year-over-year growth in revenue and profitability, leading to an upward revision of its full-year financial outlook.

Supernus Pharmaceuticals announced strong Q2 2026 results with a 32% revenue increase and raised full-year guidance, alongside a significant all-stock merger of equals with Indivior Pharmaceuticals.

Easterly Government Properties announced its second quarter 2026 results, reporting $3.2 million in net income and $37.4 million in Core FFO, while also raising its full-year 2026 Core FFO per share guidance.

Supernus Pharmaceuticals and Indivior Pharmaceuticals announced a merger of equals to create a diversified CNS biopharmaceutical company, Supernus, Inc., with expected annual revenues of $2.2 billion and $125 million in cost synergies.

Indivior Pharmaceuticals and Supernus Pharmaceuticals announced a definitive agreement to merge, creating a diversified CNS biopharmaceutical company with combined annual revenues of approximately $2.2 billion.

Kosmos Energy announced robust second quarter 2026 results, highlighted by a 12% increase in net production, significant cost reductions, and over $400 million in net debt reduction in the first half of the year.

CNH Industrial announced second quarter 2026 results, showing a 2% year-over-year increase in consolidated revenues to $4.8 billion, but a 35% decrease in net income to $141 million.

American Bitcoin Corp. reported record quarterly Bitcoin production and grew its strategic reserve to over 8,000 Bitcoin in Q2 2026, demonstrating operational strength amidst market challenges.

Integer Holdings Corporation announced a definitive agreement to be acquired by an affiliate of KKR for $5.7 billion, while reporting a 2.6% decrease in second-quarter sales.

Hughes Satellite Systems Corporation and certain U.S. subsidiaries have filed for Chapter 11 bankruptcy protection to reorganize their finances and operations.

Bit Digital announces the resignation of its Senior Vice President of Finance and Chief Accounting Officer, Justin Zhu, effective August 1, 2026, as he takes on a new role at WhiteFiber, Inc.

MDWerks, Inc. announced a non-binding Letter of Intent with Rex Lumber Company to form a joint venture focused on radio frequency-based solutions for the lumber industry.

WhiteFiber, Inc. announced significant changes to its Board of Directors and executive team, including the appointment of new directors and the transition of its CFO.

GameStop Corp. announced a private exchange of approximately $1.4 billion in convertible senior notes for shares of its Class A common stock, reducing its long-term debt without using cash.